文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肿瘤放疗抵抗的分子机制。

Molecular mechanisms of tumor resistance to radiotherapy.

机构信息

Department of Radiotherapy, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Cancer Hospital of Dalian University of Technology, No.44 Xiaoheyan Road, Dadong District, Shenyang, 110042, Liaoning Province, China.

School of Graduate, Dalian Medical University, Dalian, 116044, China.

出版信息

Mol Cancer. 2023 Jun 15;22(1):96. doi: 10.1186/s12943-023-01801-2.


DOI:10.1186/s12943-023-01801-2
PMID:37322433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10268375/
Abstract

BACKGROUND: Cancer is the most prevalent cause of death globally, and radiotherapy is considered the standard of care for most solid tumors, including lung, breast, esophageal, and colorectal cancers and glioblastoma. Resistance to radiation can lead to local treatment failure and even cancer recurrence. MAIN BODY: In this review, we have extensively discussed several crucial aspects that cause resistance of cancer to radiation therapy, including radiation-induced DNA damage repair, cell cycle arrest, apoptosis escape, abundance of cancer stem cells, modification of cancer cells and their microenvironment, presence of exosomal and non-coding RNA, metabolic reprogramming, and ferroptosis. We aim to focus on the molecular mechanisms of cancer radiotherapy resistance in relation to these aspects and to discuss possible targets to improve treatment outcomes. CONCLUSIONS: Studying the molecular mechanisms responsible for radiotherapy resistance and its interactions with the tumor environment will help improve cancer responses to radiotherapy. Our review provides a foundation to identify and overcome the obstacles to effective radiotherapy.

摘要

背景:癌症是全球最主要的死亡原因,放疗被认为是大多数实体瘤(包括肺癌、乳腺癌、食管癌、结直肠癌和胶质母细胞瘤)的标准治疗方法。对放疗的抵抗会导致局部治疗失败,甚至癌症复发。

主体:在这篇综述中,我们广泛讨论了导致癌症对放射治疗产生抵抗的几个关键方面,包括辐射诱导的 DNA 损伤修复、细胞周期阻滞、细胞凋亡逃逸、肿瘤干细胞的丰度、癌细胞及其微环境的修饰、外泌体和非编码 RNA 的存在、代谢重编程和铁死亡。我们的目的是集中讨论与这些方面相关的癌症放射治疗抵抗的分子机制,并讨论改善治疗效果的可能靶点。

结论:研究放疗抵抗的分子机制及其与肿瘤环境的相互作用将有助于提高癌症对放疗的反应。我们的综述为识别和克服有效放疗的障碍提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/eb220c7891dc/12943_2023_1801_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/6d29ef56211b/12943_2023_1801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/9bcc4846fa8e/12943_2023_1801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/f0d5cac0ff34/12943_2023_1801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/3011f3bbda0b/12943_2023_1801_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/83be2f434636/12943_2023_1801_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/eb220c7891dc/12943_2023_1801_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/6d29ef56211b/12943_2023_1801_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/9bcc4846fa8e/12943_2023_1801_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/f0d5cac0ff34/12943_2023_1801_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/3011f3bbda0b/12943_2023_1801_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/83be2f434636/12943_2023_1801_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24ba/10268375/eb220c7891dc/12943_2023_1801_Fig6_HTML.jpg

相似文献

[1]
Molecular mechanisms of tumor resistance to radiotherapy.

Mol Cancer. 2023-6-15

[2]
Radiotherapy resistance: identifying universal biomarkers for various human cancers.

J Cancer Res Clin Oncol. 2022-5

[3]
Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.

Acta Biomater. 2023-10-1

[4]
Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy.

World J Gastroenterol. 2020-4-21

[5]
Review of possible mechanisms of radiotherapy resistance in cervical cancer.

Front Oncol. 2023-8-22

[6]
A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications.

Cancer Res. 2019-1-23

[7]
DNA damage response of clinical carbon ion versus photon radiation in human glioblastoma cells.

Radiother Oncol. 2019-1-17

[8]
Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.

Adv Exp Med Biol. 2016

[9]
The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma.

Cells. 2021-2-24

[10]
Radiotherapy-induced remodeling of the tumor microenvironment by stromal cells.

Semin Cancer Biol. 2022-11

引用本文的文献

[1]
Recent advances in copper sulfide nanoparticles for cancer diagnosis and therapy.

Mater Today Bio. 2025-8-13

[2]
Genetically engineered Magnesium/Manganese nanoparticles for cancer radioimmunotherapy.

J Nanobiotechnology. 2025-8-29

[3]
Molecular and Glycosylation Pathways in Osteosarcoma: Tumor Microenvironment and Emerging Strategies Toward Personalized Oncology.

Curr Issues Mol Biol. 2025-8-7

[4]
Molecular Mechanisms of Radiation Resistance in Breast Cancer: A Systematic Review of Radiosensitization Strategies.

Curr Issues Mol Biol. 2025-7-24

[5]
Ferritin-armed extracellular vesicles with enhanced BBB penetration and tumor-targeting ability for synergistic therapy against glioblastoma.

J Nanobiotechnology. 2025-8-18

[6]
Bioinspired ruthenium-manganese-oxygen complex for biocatalytic and radiosensitization therapies to eradicate primary and metastatic tumors.

Nat Commun. 2025-8-16

[7]
MicroRNAs in the abscopal effect: bridging radiotherapy and systemic anti-tumor immunity for enhanced cancer therapy.

Clin Exp Metastasis. 2025-8-13

[8]
Radiation-induced extracellular matrix remodelling drives prognosis and predicts radiotherapy response in muscle-invasive bladder cancer.

Front Oncol. 2025-7-28

[9]
Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.

Front Pharmacol. 2025-7-25

[10]
Multifunctional gold nanoclusters as next-generation theranostic platforms for disease management.

Int J Pharm X. 2025-7-21

本文引用的文献

[1]
TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.

Nat Commun. 2023-2-16

[2]
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review.

Ann Transl Med. 2022-12

[3]
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck.

Cancer Treat Rev. 2023-2

[4]
Cancer statistics, 2023.

CA Cancer J Clin. 2023-1

[5]
TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective.

Nat Rev Immunol. 2023-6

[6]
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer Trial.

JAMA Oncol. 2022-12-1

[7]
A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer.

Signal Transduct Target Ther. 2022-10-17

[8]
Exosomal protein angiopoietin-like 4 mediated radioresistance of lung cancer by inhibiting ferroptosis under hypoxic microenvironment.

Br J Cancer. 2022-11

[9]
Inflammation: the incubator of the tumor microenvironment.

Trends Cancer. 2022-11

[10]
Functional Immune Cell-Derived Exosomes Engineered for the Trilogy of Radiotherapy Sensitization.

Adv Sci (Weinh). 2022-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索